Beam Therapeutics (BEAM) Interest & Investment Income (2019 - 2026)
Beam Therapeutics (BEAM) reported Interest & Investment Income of $9.9 million for Q1 2026, little changed year-over-year from $9.9 million in Q1 2025, and down 7.27% quarter-over-quarter from $10.6 million in Q4 2025.
Beam Therapeutics (BEAM) Interest & Investment Income (2019 - 2026) Analysis & Trends
Beam Therapeutics (BEAM) has 8 years of Interest & Investment Income data on file, last reported at $9.9 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $9.9 million, changed 0.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.7 million (down 7.16% YoY), and the FY2025 annual result was $43.7 million, down 10.92% from the prior year.
- Interest & Investment Income declined to $9.9 million in Q1 2026 per BEAM's latest filing, from $10.6 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $14.2 million in Q2 2024 and troughed at $644000.0 in Q1 2022.
- A 5-year average of $9.7 million and a median of $10.9 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 55255.56% in 2022, then fell 16.75% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $7.6 million in 2022, then jumped by 58.51% to $12.1 million in 2023, then declined by 9.42% to $10.9 million in 2024, then declined by 2.64% to $10.6 million in 2025, then slipped by 7.27% to $9.9 million in 2026.
- Business Quant data shows BEAM's Interest & Investment Income at $9.9 million in Q1 2026, $10.6 million in Q4 2025, and $10.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Beam Therapeutics | 3.53 Bn | 3.53 Bn | - | 9.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.87 Mn |
| Dec 31, 2025 | 10.64 Mn |
| Sep 30, 2025 | 10.90 Mn |
| Jun 30, 2025 | 12.33 Mn |
| Mar 31, 2025 | 9.86 Mn |
| Dec 31, 2024 | 10.93 Mn |
| Sep 30, 2024 | 12.13 Mn |
| Jun 30, 2024 | 14.19 Mn |
| Mar 31, 2024 | 11.85 Mn |
| Dec 31, 2023 | 12.06 Mn |
| Sep 30, 2023 | 12.70 Mn |
| Jun 30, 2023 | 11.95 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 7.61 Mn |
| Sep 30, 2022 | 4.98 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 644,000.00 |
| Dec 31, 2021 | 54,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | -52,000.00 |